These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
214 related items for PubMed ID: 12029555
1. FDG PET for staging of advanced non-small cell lung cancer prior to neoadjuvant radio-chemotherapy. Eschmann SM, Friedel G, Paulsen F, Budach W, Harer-Mouline C, Dohmen BM, Bares R. Eur J Nucl Med Mol Imaging; 2002 Jun; 29(6):804-8. PubMed ID: 12029555 [Abstract] [Full Text] [Related]
2. 18F-FDG PET for assessment of therapy response and preoperative re-evaluation after neoadjuvant radio-chemotherapy in stage III non-small cell lung cancer. Eschmann SM, Friedel G, Paulsen F, Reimold M, Hehr T, Budach W, Langen HJ, Bares R. Eur J Nucl Med Mol Imaging; 2007 Apr; 34(4):463-71. PubMed ID: 17103167 [Abstract] [Full Text] [Related]
3. Repeat 18F-FDG PET for monitoring neoadjuvant chemotherapy in patients with stage III non-small cell lung cancer. Eschmann SM, Friedel G, Paulsen F, Reimold M, Hehr T, Budach W, Dittmann H, Langen HJ, Bares R. Lung Cancer; 2007 Feb; 55(2):165-71. PubMed ID: 17129635 [Abstract] [Full Text] [Related]
4. [Impact of positron emission tomography on clinical management of potentially resectable non-small-cell lung cancer: a French prospective multicenter study]. Margery J, Milleron B, Vaylet F, Grahek D, Lebeau B, Mangiapan G, Bonardel G, de Labriolle-Vaylet C, Meignan M, Carette MF, Talbot JN, Housset B. Rev Pneumol Clin; 2010 Oct; 66(5):313-20. PubMed ID: 21087727 [Abstract] [Full Text] [Related]
5. Impact of staging with 18F-FDG-PET on outcome of patients with stage III non-small cell lung cancer: PET identifies potential survivors. Eschmann SM, Friedel G, Paulsen F, Reimold M, Hehr T, Scheiderbauer J, Budach W, Kotzerke J, Bares R. Eur J Nucl Med Mol Imaging; 2007 Jan; 34(1):54-9. PubMed ID: 16896660 [Abstract] [Full Text] [Related]
6. FDG PET/CT for assessing the resectability of NSCLC patients with N2 disease after neoadjuvant therapy. Kremer R, Peysakhovich Y, Dan LF, Guralnik L, Kagna O, Nir RR, Bar-Shalom R. Ann Nucl Med; 2016 Feb; 30(2):114-21. PubMed ID: 26613715 [Abstract] [Full Text] [Related]